Baricitinib 2 mg, 4 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 2 mg, 4 mg
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
Category: Anti Covid Medicines
Baricitinib (Olumiant®) is a JAK inhibitor used for rheumatoid arthritis and COVID-19 treatment in hospitalized adults, approved in the US and EU. Available in 1 mg, 2 mg, and 4 mg tablets, it’s sourced globally via PharmaB2B platforms. Connect with GMP-certified manufacturers offering Baricitinib for bulk supply, tenders, and institutional procurement, with full regulatory documentation and global export support.
Product Description: Baricitinib, marketed as Olumiant® by Eli Lilly, is a JAK inhibitor approved in the US and EU for rheumatoid arthritis and authorized for COVID-19 treatment in hospitalized adults. Available in 1 mg, 2 mg, and 4 mg oral tablets, it helps reduce inflammation and cytokine storms in severe COVID-19 cases. Through leading PharmaB2B platforms, global buyers can source Olumiant or Baricitinib generics from GMP-certified manufacturers in India, China, and Bangladesh. Ideal for hospital tenders and bulk procurement, Baricitinib is widely distributed with full regulatory support, competitive pricing, and fast international shipping.
Baricitinib — third party manufacturing & bulk supply
Baricitinib 2 mg, 4 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Baricitinib is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Baricitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Baricitinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Nirmatrelvir / Ritonavir Tablet
Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details
Tocilizumab
Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details
Favipiravir Tablet
Strength:
200 mg, 400 mg, 600 mg
Form: Tablet
Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
